For tirzepatide, that means 2.5 mg for 4 weeks, then 5 mg for 4 weeks, then potentially 7.5 mg, 10 mg, 12.5 mg, and 15 mg
However, despite the Food and Drug Administration recently raising concerns about the side effects of unapproved GLP-1s for weight loss, one-third of GLP-1 users have switched from brand-name to compounded or custom-mixed drugs
Starting at three months also gives your provider time to screen for postpartum thyroid dysfunction , which affects up to 10 percent of new mothers and can cause weight retention that GLP-1 medications will not fully address
This shows that for a meaningful number of people, the injection itself is enough to stop them from accessing treatment entirely
One of the advanced options we offer is semaglutide GLP-1, a medication that has shown remarkable effectiveness in supporting weight loss for individuals struggling with obesity or weight-related health challenges